The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages

Recent advances in understanding xenotransplantation: implications for the clinic

(2015) David KC Cooper et al.   Expert Review of Clinical Immunology

The current state of xenotransplantation

(2014) J. Zeyland et al.   JOURNAL OF APPLIED GENETICS

Co-expression of a scFv antibody fragment and a reporter protein using lentiviral shuttle plasmid containing a self-processing furin-2A sequence

(2013) Sarah L. Appleby et al.   JOURNAL OF IMMUNOLOGICAL METHODS

CD47 functions as a molecular switch for erythrocyte phagocytosis

(2012) P. Burger et al.   BLOOD

Human CD47 Expression Permits Survival of Porcine Cells in Immunodeficient Mice that Express SIRPα Capable of Binding to Human CD47

(2011) Chunfeng Wang et al.   CELL TRANSPLANTATION

1,25-Dihydroxyvitamin D3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression

(2011) Ji H. Lee et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo

(2011) Nicolas Legrand et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Versatile co-expression of graft-protective proteins using 2A-linked cassettes

(2011) Nella Fisicaro et al.   XENOTRANSPLANTATION

Xenotransplantation-The Future of Corneal Transplantation?

(2010) Hidetaka Hara et al.   CORNEA

Overcoming the barriers to xenotransplantation: prospects for the future

(2010) Burcin Ekser et al.   Expert Review of Clinical Immunology

Effects of Long-Term Administration of Recombinant Human Protein C in Xenografted Primates

(2010) Paolo Simioni et al.   TRANSPLANTATION

CD47 in the Immune Response: Role of Thrombospondin and SIRP-α Reverse Signaling

(2008) Marika Sarfati et al.   CURRENT DRUG TARGETS

Thrombospondin and Apoptosis: Molecular Mechanisms and Use for Design of Complementation Treatments

(2008) Y. Mirochnik et al.   CURRENT DRUG TARGETS